Discovery and Development of Innovative Medicines
Scholar Rock is a clinical-stage biopharmaceutical company founded on pioneering science from Harvard Medical School and Boston Children's Hospital. The company focuses on selectively targeting growth factor proteins in the TGF-beta superfamily before activation, with a pipeline spanning neuromuscular disorders, cardiometabolic conditions, immuno-oncology, fibrotic diseases, and hematology. Scholar Rock has been publicly traded on NASDAQ (SRRK) since 2018.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountMay 2018
Jan 2018
Jan 2016
Sep 2014
Create a free account to see which investors have funded this company.
Create Free Account
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Health insurance company using technology to make health care simple, affordable, and accessible.
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
